Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats

Ling Shen, Michael Haas, David Q.H. Wang, Aaron May, Chunmin C. Lo, Silvana Obici, Patrick Tso, Stephen C. Woods, Min Liu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Although ginseng has been reported to ameliorate hyperglycemia in animal models and clinical studies, the molecular mechanisms are largely unknown. We previously reported that chronic treatment with ginsenoside Rb1 (Rb1), a major component of ginseng, significantly reduced fasting glucose and improved glucose tolerance in high-fat diet (HFD)-induced obese rats. These effects were greater than those observed in pair-fed rats, suggesting a direct effect of Rb1 on glucose homeostasis, and this possibility was confirmed in the present study. In lean rats fed standard rodent chow, 5-day treatment with Rb1 significantly improved glucose tolerance and enhanced insulin sensitivity. Notably, those effects were not accompanied by reduced food intake or changed body weight. To elucidate the underlying molecular mechanisms, rats fed a HFD for 4 weeks were treated with Rb1 for 5 days. Subsequently, euglycemic- hyperinsulinemic clamp studies found that compared to vehicle, Rb1, while not changing food intake or body weight, significantly increased glucose infusion rate required to maintain euglycemia. Consistent with this, insulininduced inhibition of hepatic gluconeogenesis was significantly enhanced and hepatic phosphoenolpyruvate carboxykinase and glucose-6-phosphatase gene expression was suppressed. Additionally, glucose uptake was significantly increased in skeletal muscle. While proximal insulin signaling was not changed after Rb1 treatment, increased phosphorylation of TBC1D4, a downstream target of AMPK signaling, appears to be a key part of the mechanism for Rb1-stimulated glucose uptake in skeletal muscle. These findings indicate that Rb1 has multiple effects on glucose homeostasis, and provide strong rationale for further evaluation of its potential therapeutic role.

Original languageEnglish (US)
Article numbere12543
JournalPhysiological Reports
Volume3
Issue number9
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

AMP-Activated Protein Kinases
Insulin Resistance
Glucose
Panax
High Fat Diet
Skeletal Muscle
Homeostasis
Eating
Body Weight
Glucose-6-Phosphatase
Phosphoenolpyruvate
Glucose Clamp Technique
Gluconeogenesis
ginsenoside Rb1
Liver
Hyperglycemia
Rodentia
Fasting
Animal Models
Phosphorylation

Keywords

  • AMPK
  • Ginsenoside
  • Glucose homeostasis
  • Insulin signaling pathway
  • TBC1D4

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats. / Shen, Ling; Haas, Michael; Wang, David Q.H.; May, Aaron; Lo, Chunmin C.; Obici, Silvana; Tso, Patrick; Woods, Stephen C.; Liu, Min.

In: Physiological Reports, Vol. 3, No. 9, e12543, 01.01.2015.

Research output: Contribution to journalArticle

Shen, Ling ; Haas, Michael ; Wang, David Q.H. ; May, Aaron ; Lo, Chunmin C. ; Obici, Silvana ; Tso, Patrick ; Woods, Stephen C. ; Liu, Min. / Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats. In: Physiological Reports. 2015 ; Vol. 3, No. 9.
@article{15e76349cf754932867f3da8be2bfbc5,
title = "Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats",
abstract = "Although ginseng has been reported to ameliorate hyperglycemia in animal models and clinical studies, the molecular mechanisms are largely unknown. We previously reported that chronic treatment with ginsenoside Rb1 (Rb1), a major component of ginseng, significantly reduced fasting glucose and improved glucose tolerance in high-fat diet (HFD)-induced obese rats. These effects were greater than those observed in pair-fed rats, suggesting a direct effect of Rb1 on glucose homeostasis, and this possibility was confirmed in the present study. In lean rats fed standard rodent chow, 5-day treatment with Rb1 significantly improved glucose tolerance and enhanced insulin sensitivity. Notably, those effects were not accompanied by reduced food intake or changed body weight. To elucidate the underlying molecular mechanisms, rats fed a HFD for 4 weeks were treated with Rb1 for 5 days. Subsequently, euglycemic- hyperinsulinemic clamp studies found that compared to vehicle, Rb1, while not changing food intake or body weight, significantly increased glucose infusion rate required to maintain euglycemia. Consistent with this, insulininduced inhibition of hepatic gluconeogenesis was significantly enhanced and hepatic phosphoenolpyruvate carboxykinase and glucose-6-phosphatase gene expression was suppressed. Additionally, glucose uptake was significantly increased in skeletal muscle. While proximal insulin signaling was not changed after Rb1 treatment, increased phosphorylation of TBC1D4, a downstream target of AMPK signaling, appears to be a key part of the mechanism for Rb1-stimulated glucose uptake in skeletal muscle. These findings indicate that Rb1 has multiple effects on glucose homeostasis, and provide strong rationale for further evaluation of its potential therapeutic role.",
keywords = "AMPK, Ginsenoside, Glucose homeostasis, Insulin signaling pathway, TBC1D4",
author = "Ling Shen and Michael Haas and Wang, {David Q.H.} and Aaron May and Lo, {Chunmin C.} and Silvana Obici and Patrick Tso and Woods, {Stephen C.} and Min Liu",
year = "2015",
month = "1",
day = "1",
doi = "10.14814/phy2.12543",
language = "English (US)",
volume = "3",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats

AU - Shen, Ling

AU - Haas, Michael

AU - Wang, David Q.H.

AU - May, Aaron

AU - Lo, Chunmin C.

AU - Obici, Silvana

AU - Tso, Patrick

AU - Woods, Stephen C.

AU - Liu, Min

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Although ginseng has been reported to ameliorate hyperglycemia in animal models and clinical studies, the molecular mechanisms are largely unknown. We previously reported that chronic treatment with ginsenoside Rb1 (Rb1), a major component of ginseng, significantly reduced fasting glucose and improved glucose tolerance in high-fat diet (HFD)-induced obese rats. These effects were greater than those observed in pair-fed rats, suggesting a direct effect of Rb1 on glucose homeostasis, and this possibility was confirmed in the present study. In lean rats fed standard rodent chow, 5-day treatment with Rb1 significantly improved glucose tolerance and enhanced insulin sensitivity. Notably, those effects were not accompanied by reduced food intake or changed body weight. To elucidate the underlying molecular mechanisms, rats fed a HFD for 4 weeks were treated with Rb1 for 5 days. Subsequently, euglycemic- hyperinsulinemic clamp studies found that compared to vehicle, Rb1, while not changing food intake or body weight, significantly increased glucose infusion rate required to maintain euglycemia. Consistent with this, insulininduced inhibition of hepatic gluconeogenesis was significantly enhanced and hepatic phosphoenolpyruvate carboxykinase and glucose-6-phosphatase gene expression was suppressed. Additionally, glucose uptake was significantly increased in skeletal muscle. While proximal insulin signaling was not changed after Rb1 treatment, increased phosphorylation of TBC1D4, a downstream target of AMPK signaling, appears to be a key part of the mechanism for Rb1-stimulated glucose uptake in skeletal muscle. These findings indicate that Rb1 has multiple effects on glucose homeostasis, and provide strong rationale for further evaluation of its potential therapeutic role.

AB - Although ginseng has been reported to ameliorate hyperglycemia in animal models and clinical studies, the molecular mechanisms are largely unknown. We previously reported that chronic treatment with ginsenoside Rb1 (Rb1), a major component of ginseng, significantly reduced fasting glucose and improved glucose tolerance in high-fat diet (HFD)-induced obese rats. These effects were greater than those observed in pair-fed rats, suggesting a direct effect of Rb1 on glucose homeostasis, and this possibility was confirmed in the present study. In lean rats fed standard rodent chow, 5-day treatment with Rb1 significantly improved glucose tolerance and enhanced insulin sensitivity. Notably, those effects were not accompanied by reduced food intake or changed body weight. To elucidate the underlying molecular mechanisms, rats fed a HFD for 4 weeks were treated with Rb1 for 5 days. Subsequently, euglycemic- hyperinsulinemic clamp studies found that compared to vehicle, Rb1, while not changing food intake or body weight, significantly increased glucose infusion rate required to maintain euglycemia. Consistent with this, insulininduced inhibition of hepatic gluconeogenesis was significantly enhanced and hepatic phosphoenolpyruvate carboxykinase and glucose-6-phosphatase gene expression was suppressed. Additionally, glucose uptake was significantly increased in skeletal muscle. While proximal insulin signaling was not changed after Rb1 treatment, increased phosphorylation of TBC1D4, a downstream target of AMPK signaling, appears to be a key part of the mechanism for Rb1-stimulated glucose uptake in skeletal muscle. These findings indicate that Rb1 has multiple effects on glucose homeostasis, and provide strong rationale for further evaluation of its potential therapeutic role.

KW - AMPK

KW - Ginsenoside

KW - Glucose homeostasis

KW - Insulin signaling pathway

KW - TBC1D4

UR - http://www.scopus.com/inward/record.url?scp=84984675430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984675430&partnerID=8YFLogxK

U2 - 10.14814/phy2.12543

DO - 10.14814/phy2.12543

M3 - Article

AN - SCOPUS:84984675430

VL - 3

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 9

M1 - e12543

ER -